These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30251219)

  • 1. The Exosome: a New Player in Diabetic Cardiomyopathy.
    Tao L; Shi J; Yang X; Yang L; Hua F
    J Cardiovasc Transl Res; 2019 Feb; 12(1):62-67. PubMed ID: 30251219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective Effects of Exosomes and Their Potential Therapeutic Use.
    Ding S; Zhang J; Dai Q; Zhao M; Huang H; Xu Y; Zhong C
    Adv Exp Med Biol; 2017; 998():163-177. PubMed ID: 28936739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into the Role of Exosomes in the Heart After Myocardial Infarction.
    Li N; Rochette L; Wu Y; Rosenblatt-Velin N
    J Cardiovasc Transl Res; 2019 Feb; 12(1):18-27. PubMed ID: 30173401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.
    Salem ESB; Fan GC
    Adv Exp Med Biol; 2017; 998():113-138. PubMed ID: 28936736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects.
    Wang J; Zhao C; Xiao J
    J Cardiovasc Transl Res; 2019 Feb; 12(1):1-2. PubMed ID: 30617761
    [No Abstract]   [Full Text] [Related]  

  • 6. The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases.
    Ni J; Sun Y; Liu Z
    J Cardiovasc Transl Res; 2019 Feb; 12(1):51-61. PubMed ID: 29525884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.
    Song YH; Shao L; Zhang Y; Zhou J; Liu B; Pan X; Geng YJ; Yu XY; Li Y
    Adv Exp Med Biol; 2017; 998():187-206. PubMed ID: 28936741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue.
    Galeone A; Annicchiarico A; Buccoliero C; Barile B; Luciani GB; Onorati F; Nicchia GP; Brunetti G
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease.
    Suzuki E; Fujita D; Takahashi M; Oba S; Nishimatsu H
    Adv Exp Med Biol; 2017; 998():179-185. PubMed ID: 28936740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
    Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay of inflammation, exosomes and Ca
    Sanganalmath SK; Dubey S; Veeranki S; Narisetty K; Krishnamurthy P
    Cardiovasc Diabetol; 2023 Feb; 22(1):37. PubMed ID: 36804872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy.
    Hu J; Wang S; Xiong Z; Cheng Z; Yang Z; Lin J; Wang T; Feng X; Gao E; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3639-3649. PubMed ID: 30251683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease.
    Radosinska J; Bartekova M
    Adv Exp Med Biol; 2017; 998():221-235. PubMed ID: 28936743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes: promising sacks for treating ischemic heart disease?
    Chen GH; Xu J; Yang YJ
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H508-H523. PubMed ID: 28646026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair.
    Mol EA; Goumans MJ; Sluijter JPG
    Adv Exp Med Biol; 2017; 998():207-219. PubMed ID: 28936742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.
    Ahmad I; Hoda M
    Pharmacol Res; 2020 Nov; 161():105112. PubMed ID: 32758636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
    Nandi SS; Mishra PK
    Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.